April 27, 2012
Warner Chilcott Co. LLC on Thursday redoubled its efforts to protect its osteoporosis drug Atelvia, launching a new infringement suit accusing Ranbaxy Laboratories Ltd. of violating its patents by developing a generic version of the drug.